Preclinical studies developed on cervical cancer cell lines [114, 115] confirm even in this tumor the results obtained in murine model from Baselga group: both chemo and radiotherapy join of cetuximab coadministration effects but apparently in a less EGFR-dependent way [115]. The gene discussed is EGFR; the disease is cervical carcinoma.